Jyong Biotech Ltd. (NASDAQ:MENS - Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $40.41, but opened at $38.82. Jyong Biotech shares last traded at $37.00, with a volume of 21,808 shares changing hands.
Wall Street Analyst Weigh In
Separately, Wall Street Zen raised shares of Jyong Biotech to a "hold" rating in a research report on Monday, June 30th.
Read Our Latest Stock Analysis on MENS
Jyong Biotech Price Performance
About Jyong Biotech
(
Get Free Report)
OUR MISSION We endeavor to develop and supply first-class innovative drugs to meet our customers' health needs. We seek to be a valuable business organization that is held in high esteem by the public. We are a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU, and Asia.
Further Reading
Before you consider Jyong Biotech, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jyong Biotech wasn't on the list.
While Jyong Biotech currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access